Scalper1 News
Embattled specialty drugmaker Allergan (AGN) beat Wall Street’s Q1 estimates and raised its guidance Wednesday, but shares remained flat in the stock market today. Allergan reported earnings of $1.18 a share, up 20% from the year-earlier quarter and beating analysts’ consensus by 5 cents. Sales rose 13% to $1.62 billion, in line with estimates. Guidance followed a similar pattern. For the full year, the company set a sales range of $6.78 billion Scalper1 News
Scalper1 News